Product image of Levosimendan Kalceks (Levosimendan) supplied by GNH India

Levosimendan Kalceks

Active Ingredient:
Levosimendan
Origin:
EU

Levosimendan Kalceks (Levosimendan)

Levosimendan, the active ingredient in Levosimendan Kalceks, is a calcium sensitizer presented as an intravenous solution for intravenous use. It is used to improve cardiac contractility in patients with acute decompensated heart failure.
GNH India supplies Levosimendan Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levosimendan is employed in the management of heart failure syndromes where enhanced contractility is required.

  • Acute decompensated heart failure: improves cardiac output and relieves symptoms of low output.
  • Severe chronic heart failure (inotropic support): provides temporary hemodynamic improvement during critical periods.

How It Works

  • Levosimendan binds to cardiac troponin C, increasing its sensitivity to calcium and thereby enhancing myocardial contractility without raising intracellular calcium levels. It also opens ATP‑sensitive potassium channels in vascular smooth muscle, causing arterial and venous vasodilation, which reduces cardiac preload and afterload.

Side Effects

Levosimendan may be associated with several adverse reactions.

Common Side Effects

  • Hypotension: reduction in blood pressure, especially during rapid infusion.
  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal discomfort.
  • Tachycardia: increased heart rate during treatment.

Serious or Rare Side Effects

  • Ventricular arrhythmias: potentially life‑threatening rhythm disturbances.
  • Myocardial ischemia: chest pain due to reduced coronary perfusion.
  • Severe hypotension: marked drop in blood pressure requiring intervention.
  • Allergic reactions: rash, pruritus, or anaphylaxis in susceptible individuals.

Precautions & Warnings

Levosimendan requires careful monitoring and specific safety measures before and during administration.

  • Cardiovascular monitoring: continuously observe blood pressure and heart rate during infusion.
  • Renal impairment: adjust therapy in patients with severe renal dysfunction.
  • Hepatic impairment: use cautiously in advanced liver disease.
  • Concomitant vasodilators: avoid excessive hypotension by limiting combined use.
  • Electrolyte disturbances: correct potassium and magnesium abnormalities prior to infusion.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levosimendan can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid)

  • Sodium nitroprusside: additive hypotensive effect.
  • Phosphodiesterase inhibitors (e.g., milrinone): risk of severe hypotension.
  • Beta‑blockers: may blunt the intended inotropic response.
  • Calcium channel blockers: increase the likelihood of arrhythmias.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor for excessive blood pressure reduction.
  • Diuretics: watch electrolyte levels and volume status.

Frequently Asked Questions

Levosimendan Kalceks is an intravenous calcium sensitizer indicated for the treatment of acute decompensated heart failure. It helps improve cardiac contractility and reduces symptoms associated with low cardiac output in hospitalized patients.

Levosimendan enhances the sensitivity of troponin C to calcium, which strengthens heart muscle contraction without increasing intracellular calcium. It also opens ATP‑sensitive potassium channels in blood vessels, producing vasodilation that lowers preload and afterload.

The dosing regimen for levosimendan is determined by the prescribing clinician based on the patient’s clinical status, weight, and renal function. The prescriber will set the infusion rate and duration according to approved guidelines.

Safety data for levosimendan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike traditional catecholamine inotropes, levosimendan increases contractility by sensitizing troponin C to calcium and causes vasodilation through potassium‑channel activation. This dual action can result in improved cardiac output with a lower risk of tachyarrhythmias compared with agents such as dobutamine.

Levosimendan Kalceks should be stored at 2‑8 °C, protected from light, and must not be frozen. The product should be kept in its original packaging until ready for reconstitution and administration.

Levosimendan is given as an intravenous infusion, typically initiated with a loading dose followed by a continuous maintenance infusion. Administration is performed by qualified healthcare personnel in a monitored clinical setting.

The most serious risks include severe hypotension, ventricular arrhythmias, myocardial ischemia, and rare allergic reactions. Continuous cardiovascular monitoring is essential to detect and manage these events promptly.

Levosimendan is contraindicated in patients with known hypersensitivity to the drug, those with severe hypotension unresponsive to treatment, and individuals with significant mechanical obstruction of the outflow tract of the heart. Caution is also advised in severe renal or hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levosimendan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT